Adaptive immune responses and immunity to SARS-CoV-2

D Primorac, K Vrdoljak, P Brlek, E Pavelić… - Frontiers in …, 2022 - frontiersin.org
Since the onset of the COVID-19 pandemic, the medical field has been forced to apply the
basic knowledge of immunology with the most up-to-date SARS-CoV-2 findings and …

Enhancement of SARS-coV-2 N antigen-specific T cell functionality by modulating the autophagy-mediated signal pathway in mice

Z Wen, Y Yuan, Y Zhao, H Wang, Z Han, M Li, J Yuan… - Viruses, 2023 - mdpi.com
The frequent SARS-CoV-2 variants have caused a continual challenge, weakening the
effectiveness of current vaccines, and thus it is of great importance to induce robust and …

Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination

L Blixt, Y Gao, D Wullimann… - Blood, The Journal …, 2022 - ashpublications.org
COI notes: The authors declare no competing financial interests. MB is a consultant for
Oxford Immunotech. AS is a consultant for Gritstone Bio, Flow Pharma, Arcturus …

Study of the cellular and humoral immune responses to SARS-CoV-2 vaccination

F Montmaneix-Engels, C Dimeglio, L Staes, I Da-Silva… - Heliyon, 2024 - cell.com
Our understanding of cellular immunity in response to COVID-19 infection or vaccination is
limited because of less commonly used techniques. We investigated both the cellular and …

Importance of Cellular Immunity and IFN-γ Concentration in Preventing SARS-CoV-2 Infection and Reinfection: A Cohort Study

D Primorac, P Brlek, ES Pavelić, J Mešić… - Viruses, 2023 - mdpi.com
Recent studies have highlighted the underestimated importance of the cellular immune
response after the emergence of variants of concern (VOCs) of SARS-CoV-2, and the …

Durability of humoral and cellular immunity after an extended primary series with heterologous inactivated SARS-Cov-2 prime-boost and Chadox1 NCOV-19 in …

S Boongird, C Setthaudom, R Kitpermkiat… - Vaccines, 2022 - mdpi.com
The durability of a three-dose extended primary series of COVID-19 vaccine in dialysis
patients remains unknown. Here, we assessed dynamic changes in SARS-CoV-2-specific …

Inflammation and Immune Reactions in the Fetus as a Response to COVID-19 in the Mother

NR Gashimova, LL Pankratyeva, VO Bitsadze… - Journal of Clinical …, 2023 - mdpi.com
Background: Contracting COVID-19 during pregnancy can harm both the mother and the
unborn child. Pregnant women are highly likely to develop respiratory viral infection …

Humoral and Cellular Response and Associated Variables Nine Months following BNT162b2 Vaccination in Healthcare Workers

N Syrimi, F Sourri, MC Giannakopoulou… - Journal of Clinical …, 2023 - mdpi.com
In this study, we aimed to illustrate the trajectory of humoral and cellular immunity nine
months after primary vaccination with the BNT162b2 mRNA vaccine among 189 healthcare …

[HTML][HTML] Comparison of four T-cell assays and two binding antibody assays in SARS-CoV-2 vaccinees with or without Omicron breakthrough infection

YJ Seo, I Oh, M Nam, S Shin, EY Roh… - Annals of laboratory …, 2023 - ncbi.nlm.nih.gov
Background Several T-cell response assays for severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) are available; however, their comparability and correlations …

Comparison of two commercially available interferon-γ release assays for T-cell-mediated immunity and evaluation of humoral immunity against SARS-CoV-2 in …

A Lochmanová, J Martinek, H Tomášková, H Zelená… - Diagnostics, 2023 - mdpi.com
Cellular immunity against SARS-CoV-2 is an important component of the immune response
to the virus. At present, two such tests based on interferon-gamma release (interferon-γ …